6/18/2019
Spencer Platt/Getty Images

Pfizer announced Monday that it plans to purchase oncology drug manufacturer Array BioPharma for $11.4 billion, and the news sent shares of other companies in the cancer therapeutics space higher. The move indicates more deals will be forthcoming, according to Jefferies strategist Jared Holz.

Full Story:
MarketWatch

Related Summaries